Normal adrenal function in an infant following a pregnancy complicated by maternal adrenal cortical carcinoma and mitotane exposure

J Pediatr Endocrinol Metab. 2011;24(3-4):203-4. doi: 10.1515/jpem.2011.123.

Abstract

Maternal adrenal cortical carcinoma in pregnancy is rare. We report a case of an infant born to a mother with a history of adrenal cortical carcinoma. The pregnancy was complicated by fetal exposure to mitotane and dexamethasone. Despite the potential teratogenic exposures, there was no evidence of adrenal dysfunction in the infant. Growth and development at 12 months of age are normal and prognosis appears favorable. The long-term impact of fetal exposure to mitotane and glucocorticoid requires further investigation.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Neoplasms / drug therapy*
  • Adrenal Glands / drug effects*
  • Adrenal Glands / embryology
  • Adrenal Glands / physiology
  • Adrenocortical Carcinoma / drug therapy*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Dexamethasone / therapeutic use*
  • Female
  • Humans
  • Infant
  • Male
  • Maternal Exposure*
  • Mitotane / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Young Adult

Substances

  • Antineoplastic Agents, Hormonal
  • Mitotane
  • Dexamethasone